PODCAST · health
Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists
by Annenberg Center for Health Sciences
In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease.
-
7
Cardiologist Collaboration
Role in Diabetes Management Multidisciplinary Team-based Approach
-
6
Individualizing Therapy
Drug Initiation and Monitoring Contraindications and Adverse Effects Patient Education
-
5
Cardiovascular Benefits
FDA Indications Clinical Trial Evidence
-
4
Glycemic/Non-Glycemic Effects
Short-Acting versus Long-Acting Agents Fasting and Postprandial Blood Glucose Gastric Emptying and Body Weight
-
3
Pathophysiologic Targets
Diabetes Pathophysiology Glucagon-Like Peptide-1 Mechanisms
-
2
Guideline Recommendations
Diabetes Guidelines Chronic Coronary Disease Guidelines
-
1
Introduction and Case Vignettes
Meet Jorge Plutzky, MD and Helena Rodbard, MD. This episode covers: Faculty Introduction Case Vignettes Cardiovascular Risk Reduction
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease.
HOSTED BY
Annenberg Center for Health Sciences
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists have?
Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists currently has 7 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists about?
In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate...
How often does Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists release new episodes?
Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists has 7 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists?
You can listen to Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists?
Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists is created and hosted by Annenberg Center for Health Sciences.
URL copied to clipboard!